Comparison between Nisus Finance IPO and Onyx Biotec IPO.
Nisus Finance IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Onyx Biotec IPO is a SME Bookbuilding proposed to list at NSE SME.
| Nisus Finance IPO | Onyx Biotec IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Beeline Capital Advisors Pvt.Ltd. | Horizon Management Pvt.Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | MAS Services Ltd. |
| Market Maker | Spread X Securities Pvt.Ltd. | Giriraj Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Nisus Finance IPO is up to ₹107.91 Cr whereas the issue size of the Onyx Biotec IPO is up to ₹27.85 Cr. The final issue price of Nisus Finance IPO is ₹180.00 per share and of Onyx Biotec IPO is ₹61.00 per share.
| Nisus Finance IPO | Onyx Biotec IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹170.00 per share | ₹58.00 per share |
| Issue Price (Upper) | ₹180.00 per share | ₹61.00 per share |
| Issue Price (Final) | ₹180.00 per share | ₹61.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 800 shares | 2000 shares |
| Fresh Issue Size | 52,94,400 shares | 45,66,000 shares |
| Fresh Issue Size (Amount) | up to ₹95.30 Cr | up to ₹27.85 Cr |
| OFS Issue Size | 7,00,800 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹12.61 Cr | up to ₹0.00 Cr |
| Issue Size Total | 59,95,200 shares | 45,66,000 shares |
| Issue Size Total (Amount) | up to ₹107.91 Cr | up to ₹27.85 Cr |
Nisus Finance IPO opens on Dec 04, 2024, while Onyx Biotec IPO opens on Nov 13, 2024. The closing date of Nisus Finance IPO and Onyx Biotec IPO is Dec 06, 2024, and Nov 18, 2024, respectively.
| Nisus Finance IPO | Onyx Biotec IPO | |
|---|---|---|
| Anchor Bid Date | Dec 03, 2024 | Nov 12, 2024 |
| Issue Open | Dec 04, 2024 | Nov 13, 2024 |
| Issue Close | Dec 06, 2024 | Nov 18, 2024 |
| Basis Of Allotment (Tentative) | Dec 09, 2024 | Nov 19, 2024 |
| Initiation of Refunds (Tentative) | Dec 10, 2024 | Nov 20, 2024 |
| Credit of Share (Tentative) | Dec 10, 2024 | Nov 20, 2024 |
| Listing date (Tentative) | Dec 11, 2024 | Nov 22, 2024 |
| Anchor Lockin End date 1 | Jan 08, 2025 | Dec 19, 2024 |
| Anchor Lockin End date 2 | Mar 09, 2025 | Feb 17, 2025 |
Nisus Finance IPO P/E ratio is 14.24, as compared to Onyx Biotec IPO P/E ratio of 26.81.
| Nisus Finance IPO | Onyx Biotec IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.74 | 88.6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.22 | 65.1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 14.24 | 26.81 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹429.81 Cr. | ₹110.61 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 109.83 | 4.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 101.63 | 3.71 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.23 | 1.21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹12.64 | ₹2.28 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 73.09 | 4.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Nisus Finance IPO Retail Individual Investors (RII) are offered 20,91,200 shares while in Onyx Biotec IPO retail investors are offered 20,91,200 shares. Qualified Institutional Buyers (QIB) are offered 11,94,400 shares in Nisus Finance IPO and 9,12,000 shares in Onyx Biotec IPO.
| Nisus Finance IPO | Onyx Biotec IPO | |
|---|---|---|
| Anchor Investor Reservation | 17,89,600 shares | 13,66,000 shares |
| Market Maker Reservation | 3,51,200 shares | 2,44,000 shares |
| QIB | 11,94,400 shares | 9,12,000 shares |
| NII | 8,96,000 shares | 6,88,000 shares |
| RII | 20,91,200 shares | 16,00,000 shares |
| Employee | 24,000 shares | |
| Others | ||
| Total | 59,95,200 shares | 45,66,000 shares |
Nisus Finance IPO subscribed 134.89x in total, whereas Onyx Biotec IPO subscribed 138.77x.
| Nisus Finance IPO | Onyx Biotec IPO | |
|---|---|---|
| QIB (times) | 93.84x | 32.49x |
| NII (times) | 451.21x | 602.86x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 139.78x | 118.26x |
| Employee (times) | 0.90x | |
| Other (times) | ||
| Total (times) | 134.89x | 138.77x |
